GPAFX | RMFCX | GPAFX / RMFCX | |
Total Expense Ratio | 0.89 | 0.91 | 98% |
Annual Report Gross Expense Ratio | 0.91 | 0.91 | 100% |
Fund Existence | 53 years | 23 years | - |
Gain YTD | 5.905 | 10.721 | 55% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 522M | 110B | 0% |
Annual Yield % from dividends | 0.89 | 1.26 | 71% |
Returns for 1 year | -3.42 | 7.77 | -44% |
Returns for 3 years | 11.18 | 22.69 | 49% |
Returns for 5 years | 34.78 | 54.95 | 63% |
Returns for 10 years | 6.27 | 79.02 | 8% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 138.76 | 1.49 | +1.09% |
iShares Biotechnology ETF | |||
SCHJ | 24.84 | 0.01 | +0.04% |
Schwab 1-5 Year Corporate Bond ETF | |||
SEPP | 29.14 | -0.02 | -0.07% |
PGIM S&P 500 Buffer 12 ETF - Sep | |||
MHF | 6.85 | -0.04 | -0.58% |
Western Asset Municipal High Income Fund | |||
DEEP | 35.08 | -0.21 | -0.60% |
Acquirers Small and Micro Deep Value ETF |